Raj Bhardwaj

Raj has extensive pharmaceutical industry/consulting experience in clinical pharmacology and nonclinical DMPK/ADME. He has deep expertise in designing clinical pharmacology plans/studies, including first in human, special population, drug-drug interaction, bioavailability, bioequivalence, QTc, and ADME studies. He also plans and implements pharmacokinetic data analysis, PK/PD, TK, PBPK, and nonclinical studies for drug metabolism and pharmacokinetics and prepares Investigator Brochures, briefing books, IND, CTD, and clinical pharmacology modules.

Raj has a proven track record working in cross-functional teams, including bio-analytics, pharmacometrics, clinical development, toxicology, drug discovery and regulatory affairs for the conduct and interpretation of preclinical and clinical studies Furthermore, he has participated and presented the results in group and project meetings and building effective technical collaborations in a team model environment.